
### [MONDO:0020111](http://purl.obolibrary.org/obo/MONDO_0020111)
**Label:** constitutional megaloblastic anemia due to folate metabolism disorder

**Subclasses:** [MONDO:0009240](http://purl.obolibrary.org/obo/MONDO_0009240) (Formiminoglutamic aciduria), [MONDO:0009238](http://purl.obolibrary.org/obo/MONDO_0009238) (hereditary folate malabsorption), [MONDO:0013456](http://purl.obolibrary.org/obo/MONDO_0013456) (constitutional megaloblastic anemia with severe neurologic disease), 

**Mapped go classes:** [GO:0060047](http://purl.obolibrary.org/obo/GO_0060047) (heart contraction), [GO:0007010](http://purl.obolibrary.org/obo/GO_0007010) (cytoskeleton organization), [GO:0015232](http://purl.obolibrary.org/obo/GO_0015232) (heme transporter activity), [GO:0015078](http://purl.obolibrary.org/obo/GO_0015078) (hydrogen ion transmembrane transporter activity), [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding), [GO:0015350](http://purl.obolibrary.org/obo/GO_0015350) (methotrexate transmembrane transporter activity), [GO:0046655](http://purl.obolibrary.org/obo/GO_0046655) (folic acid metabolic process), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0046653](http://purl.obolibrary.org/obo/GO_0046653) (tetrahydrofolate metabolic process), [GO:0005793](http://purl.obolibrary.org/obo/GO_0005793) (endoplasmic reticulum-Golgi intermediate compartment), [GO:0046654](http://purl.obolibrary.org/obo/GO_0046654) (tetrahydrofolate biosynthetic process), [GO:0004146](http://purl.obolibrary.org/obo/GO_0004146) (dihydrofolate reductase activity), [GO:0044237](http://purl.obolibrary.org/obo/GO_0044237) (cellular metabolic process), [GO:0030868](http://purl.obolibrary.org/obo/GO_0030868) (smooth endoplasmic reticulum membrane), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0051000](http://purl.obolibrary.org/obo/GO_0051000) (positive regulation of nitric-oxide synthase activity), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:0003729](http://purl.obolibrary.org/obo/GO_0003729) (mRNA binding), [GO:0070402](http://purl.obolibrary.org/obo/GO_0070402) (NADPH binding), [GO:0017148](http://purl.obolibrary.org/obo/GO_0017148) (negative regulation of translation), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0015884](http://purl.obolibrary.org/obo/GO_0015884) (folic acid transport), [GO:0009165](http://purl.obolibrary.org/obo/GO_0009165) (nucleotide biosynthetic process), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:1902600](http://purl.obolibrary.org/obo/GO_1902600) (hydrogen ion transmembrane transport), [GO:0000900](http://purl.obolibrary.org/obo/GO_0000900) (translation repressor activity, nucleic acid binding), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0006730](http://purl.obolibrary.org/obo/GO_0006730) (one-carbon metabolic process), [GO:0031427](http://purl.obolibrary.org/obo/GO_0031427) (response to methotrexate), [GO:0006729](http://purl.obolibrary.org/obo/GO_0006729) (tetrahydrobiopterin biosynthetic process), [GO:2000121](http://purl.obolibrary.org/obo/GO_2000121) (regulation of removal of superoxide radicals), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0031103](http://purl.obolibrary.org/obo/GO_0031103) (axon regeneration), [GO:0030412](http://purl.obolibrary.org/obo/GO_0030412) (formimidoyltetrahydrofolate cyclodeaminase activity), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0006545](http://purl.obolibrary.org/obo/GO_0006545) (glycine biosynthetic process), [GO:0003232](http://purl.obolibrary.org/obo/GO_0003232) (bulbus arteriosus development), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0005215](http://purl.obolibrary.org/obo/GO_0005215) (transporter activity), [GO:0008517](http://purl.obolibrary.org/obo/GO_0008517) (folic acid transmembrane transporter activity), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0030407](http://purl.obolibrary.org/obo/GO_0030407) (formimidoyltransferase activity), [GO:0030409](http://purl.obolibrary.org/obo/GO_0030409) (glutamate formimidoyltransferase activity), [GO:1990825](http://purl.obolibrary.org/obo/GO_1990825) (sequence-specific mRNA binding), [GO:0015886](http://purl.obolibrary.org/obo/GO_0015886) (heme transport), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0000329](http://purl.obolibrary.org/obo/GO_0000329) (fungal-type vacuole membrane), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:1904447](http://purl.obolibrary.org/obo/GO_1904447) (folic acid import across plasma membrane), [GO:0005542](http://purl.obolibrary.org/obo/GO_0005542) (folic acid binding), [GO:0008017](http://purl.obolibrary.org/obo/GO_0008017) (microtubule binding), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0006547](http://purl.obolibrary.org/obo/GO_0006547) (histidine metabolic process), [GO:0050661](http://purl.obolibrary.org/obo/GO_0050661) (NADP binding), [GO:0051871](http://purl.obolibrary.org/obo/GO_0051871) (dihydrofolic acid binding), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0006548](http://purl.obolibrary.org/obo/GO_0006548) (histidine catabolic process), [GO:0031526](http://purl.obolibrary.org/obo/GO_0031526) (brush border membrane), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0048598](http://purl.obolibrary.org/obo/GO_0048598) (embryonic morphogenesis), [GO:0051870](http://purl.obolibrary.org/obo/GO_0051870) (methotrexate binding), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0046452](http://purl.obolibrary.org/obo/GO_0046452) (dihydrofolate metabolic process), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0051958](http://purl.obolibrary.org/obo/GO_0051958) (methotrexate transport), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), 

**Class expressions from DL-Learner:**

- Thing 53.32%
- [GO:0031526](http://purl.obolibrary.org/obo/GO_0031526) (brush border membrane) 51.85%
- [GO:0030868](http://purl.obolibrary.org/obo/GO_0030868) (smooth endoplasmic reticulum membrane) 51.85%
- [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane) 51.85%
- [GO:0000329](http://purl.obolibrary.org/obo/GO_0000329) (fungal-type vacuole membrane) 51.85%
- [GO:0098852](http://purl.obolibrary.org/obo/GO_0098852) (lytic vacuole membrane) 37.21%
- [GO:0005774](http://purl.obolibrary.org/obo/GO_0005774) (vacuolar membrane) 37.21%
- [GO:0098852](http://purl.obolibrary.org/obo/GO_0098852) (lytic vacuole membrane) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 37.21%
- [GO:0098852](http://purl.obolibrary.org/obo/GO_0098852) (lytic vacuole membrane) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 37.21%
- [GO:0098852](http://purl.obolibrary.org/obo/GO_0098852) (lytic vacuole membrane) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 37.21%
- [GO:0098852](http://purl.obolibrary.org/obo/GO_0098852) (lytic vacuole membrane) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 37.21%
- [GO:0098852](http://purl.obolibrary.org/obo/GO_0098852) (lytic vacuole membrane) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 37.21%
- [GO:0098852](http://purl.obolibrary.org/obo/GO_0098852) (lytic vacuole membrane) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 37.21%
- [GO:0098852](http://purl.obolibrary.org/obo/GO_0098852) (lytic vacuole membrane) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 37.21%
- [GO:0098852](http://purl.obolibrary.org/obo/GO_0098852) (lytic vacuole membrane) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 37.21%


